Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Jiaweimojie tablet for primary dysmenorrhea
ChiCTR2100049936Phase 2Recruiting
- Sponsor
- Hangzhou Hospital of Traditional Chinese Medicine
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary dysmenorrhea (PD) comparing High dose Jiaweimojie tablet, Low dose Jiaweimojie tablet plus placebo and Placebo (3 arms). Primary endpoints: VAS score of the most painful degree of dysmenorrhea, Duration of dysmenorrhea and 7 more. Started Aug 2021; status: recruiting.
02
Drugs
jiaweimojie
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on ChiCTR2100049936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049936.